Kyle D. Wood

Kyle D. Wood

Auto-generated profile, based on publicly available information

Kyle D. Wood

Department of Urology, University of Alabama at Birmingham, Birmingham, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJoseph Crivelli
Joseph Crivelli
TMTanecia Mitchell
Tanecia Mitchell
JKJohn Knight
John Knight
KWKyle D. Wood
Kyle D. Wood
DADean G. Assimos
Dean G. Assimos
SFSonia Fargue
Sonia Fargue
Kidney stone disease is increasing in prevalence, and the most common stone composition is calcium oxalate. Dietary oxalate intake and endogenous production of oxalate are important in the pathophysiology of calcium oxalate stone disease. The impact of dietary oxalate intake on urinary oxalate excretion and kidney stone disease risk has been assessed through large cohort studies as well as smaller studies with dietary control. Net gastrointestinal oxalate absorption influences urinary oxalate excretion. Oxalate-degrading bacteria in the gut microbiome, especially Oxalobacter formigenes, may mitigate stone risk through reducing net oxalate absorption. Ascorbic acid (vitamin C) is the main dietary precursor for endogenous production of oxalate with several other compounds playing a lesser role. Renal handling of oxalate and, potentially, renal synthesis of oxalate may contribute to stone formation. In this review, we discuss dietary oxalate and precursors of oxalate, their pertinent physiology in humans, and what is known about their role in kidney stone disease.

22 June 2022 in BioDrugs
Verified
Journal Article
Closed access
PDF file
KSKathryn Sawyer
Kathryn Sawyer
SLStephen Leahy
Stephen Leahy
KWKyle D. Wood
Kyle D. Wood

30 January 2025 in Current Opinion in Nephrology and Hypertension
Verified
Journal Article
Closed access
OCOwen P. Cunneely
Owen P. Cunneely
ARAnne Roberts
Anne Roberts
SFSonia Fargue
Sonia Fargue
JKJohn Knight
John Knight
DADean G. Assimos
Dean G. Assimos
KWKyle D. Wood
Kyle D. Wood
Purpose of review: Metabolic dysfunction associated steatotic liver disease (MASLD) is increasing throughout the world, affecting nearly one in three individuals. Kidney stone disease, which is also increasing, is associated with MASLD. Common risk factors for both, including obesity, diabetes, dyslipidemia, hypertension, and metabolic syndrome, are likely drivers of this association. We present here a review of the associations and possible interconnections between these two common disease processes. Recent findings: Epidemiological studies are discordant regarding the impact of sex on this association and on the impact of MASLD on incident stone risk. The nature of kidney stones is rarely taken into account. A favorable milieu for uric acid kidney stone formation may be created by a lower urine pH resulting from defective ammonium production associated with insulin resistance, common in MASLD. Endogenous oxalate synthesis, a major risk factor for calcium oxalate kidney stones, may be increased in MASLD via decline in the activity of enzymes involved in the detoxification of glyoxylate, the immediate precursor of oxalate. Summary: The nature of kidney stones associated with MASLD and factors driving this association remain to be elucidated. Potential mechanisms identified underlying this include an increase in the risk factors for both uric acid and calcium oxalate kidney stones.

20 September 2021 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
XLXingsheng Li
Xingsheng Li
SFSonia Fargue
Sonia Fargue
ACAnil Kumar Challa
Anil Kumar Challa
WPWilliam Poore
William Poore
JKJohn Knight
John Knight
KWKyle D. Wood
Kyle D. Wood
Hydroxyacylglutathione hydrolase (aka as GLO-2) is a component of the glyoxalase pathway involved in the detoxification of the reactive oxoaldehydes, glyoxal and methylglyoxal. These reactive metabolites have been linked to a variety of pathological conditions, including diabetes, cancer and heart disease and may be involved in the aging process. The objective of this study was to generate a mouse model deficient in GLO-2 to provide insight into the function of GLO-2 and to determine if it is potentially linked to endogenous oxalate synthesis which could influence urinary oxalate excretion. A GLO-2 knock out mouse was generated using CRISPR/Cas 9 techniques. Tissue and 24-h urine samples were collected under baseline conditions from adult male and female animals for biochemical analyses, including chromatographic measurement of glycolate, oxalate, glyoxal, methylglyoxal, D-lactate, ascorbic acid and glutathione levels. The GLO-2 KO animals developed normally and there were no changes in 24-h urinary oxalate excretion, liver levels of methylglyoxal, glyoxal, ascorbic acid and glutathione, or plasma d-lactate levels. GLO-2 deficient males had lower plasma glycolate levels than wild type males while this relationship was not observed in females. The lack of a unique phenotype in a GLO-2 KO mouse model under baseline conditions is consistent with recent evidence, suggesting a functional glyoxalase pathway is not required for optimal health. A lower plasma glycolate in male GLO-2 KO animals suggests glyoxal production may be a significant contributor to circulating glycolate levels, but not to endogenous oxalate synthesis.

18 March 2024 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
MBMatthew C. Breeggemann
Matthew C. Breeggemann
PHPeter C. Harris
Peter C. Harris
JLJohn C. Lieske
John C. Lieske
GTGregory E Tasian
Gregory E Tasian
KWKyle D. Wood
Kyle D. Wood
An abstract is unavailable. This article is available as a PDF only.

24 July 2021 in Uro
Verified
Journal Article
Open access
PDF file
HPHenry Paiste
Henry Paiste
Luke MoradiLuke Moradi
Luke Moradi
DADean G. Assimos
Dean G. Assimos
KWKyle D. Wood
Kyle D. Wood
Pankaj DanglePankaj Dangle
Pankaj Dangle
Objectives: To examine the most recent literature and published science in determining any and all possible associations between pediatric obesity and pediatric urolithiasis. Methods: Retrospective literature review of pediatric stone formers with diagnosed stone disease and all associated risk factors. Peer-reviewed, published manuscripts from the past several decades were analyzed for risk factors associated with pediatric obesity such as diet, hypertension, and renal diseases. Comparing the pediatric obesity literature with the pediatric stone forming literature, any associations and correlations were derived and analyzed. Results: Despite the existing evidence that obesity is linked to stones in adults, the evidence remains unclear whether obesity plays a role in children. Nutritional discrepancies, in the setting of the obesity epidemic, have been shown to alter the risk profile of pediatric patients. Consistent with the published literature, and lack of consistent correlation with obesity and stone disease, is the knowledge that age, gender, geography, and climate may all play a role in the onset of pediatric obesity and may also be on the causal pathway toward pediatric urolithiasis. Conclusion: The manuscript demonstrates that there are a number of risk factors, congenital or acquired, that are associated with pediatric obesity. The mechanisms responsible for these associations may be on the causal pathway toward childhood urolithiasis. These mechanisms that underlie these associations need to be further investigated.